AU2002304785A1 - Use of cysteine protease-inhibitors for treating illnesses - Google Patents

Use of cysteine protease-inhibitors for treating illnesses

Info

Publication number: AU2002304785A1
Authority: AU; Australia
Prior art keywords: inhibitors; cysteine protease; treating illnesses; illnesses; treating
Prior art date: 2001-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002304785A

Inventor

Wilfried Lubisch

Achim Moeller

Heinz Neuhof

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott GmbH and Co KG

Original Assignee

Abbott GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-26

Filing date

2002-03-26

Publication date

2003-10-08

2002-03-26 Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG

2003-10-08 Publication of AU2002304785A1 publication Critical patent/AU2002304785A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002304785A 2001-03-26 2002-03-26 Use of cysteine protease-inhibitors for treating illnesses Abandoned AU2002304785A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10114762.7		2001-03-26
DE10114762A DE10114762A1 (en)	2001-03-26	2001-03-26	Treatment of lung diseases, especially adult respiratory distress syndrome, by administration of cysteine protease inhibitor, especially calpain inhibitor
PCT/EP2002/003399 WO2003080182A1 (en)	2001-03-26	2002-03-26	Use of cysteine protease-inhibitors for treating illnesses

Publications (1)

Publication Number	Publication Date
AU2002304785A1 true AU2002304785A1 (en)	2003-10-08

Family

ID=7679056

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002304785A Abandoned AU2002304785A1 (en)	2001-03-26	2002-03-26	Use of cysteine protease-inhibitors for treating illnesses

Country Status (3)

Country	Link
AU (1)	AU2002304785A1 (en)
DE (1)	DE10114762A1 (en)
WO (1)	WO2003080182A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101616908B (en)	2006-12-29	2014-09-10	Abbvie德国有限责任两合公司	Carboxamide compounds and their use as calpain inhibitors
TWI453019B (en)	2007-12-28	2014-09-21	Abbvie Deutschland	Carboxamide compounds
WO2009145956A2 (en) *	2008-03-06	2009-12-03	The Trustees Of Columbia University In The City Of New York	Uses of calpain inhibitors to inhibit inflammation
TWI519530B (en)	2009-02-20	2016-02-01	艾伯維德國有限及兩合公司	Carboxamide compounds and their use as calpain inhibitors
US8236798B2 (en)	2009-05-07	2012-08-07	Abbott Gmbh & Co. Kg	Carboxamide compounds and their use as calpain inhibitors
US8598211B2 (en)	2009-12-22	2013-12-03	Abbvie Inc.	Carboxamide compounds and their use as calpain inhibitors IV
US9051304B2 (en)	2009-12-22	2015-06-09	AbbVie Deutschland GmbH & Co. KG	Carboxamide compounds and their use as calpain inhibitors V
EP2648731B1 (en)	2010-12-09	2017-01-25	Abbvie Deutschland GmbH & Co. KG	Carboxamide compounds and their use as calpain inhibitors v
CA2867210A1 (en)	2012-04-03	2013-10-10	AbbVie Deutschland GmbH & Co. KG	Carboxamide compounds and their use as calpain inhibitors v
EP3426674A4 (en)	2016-03-09	2019-08-14	Blade Therapeutics, Inc.	CYCLIC CE-AMIDE COMPOUNDS AS MODULATORS OF CALPAIN, AND METHODS OF MAKING AND USING SAME
US11292801B2 (en)	2016-07-05	2022-04-05	Blade Therapeutics, Inc.	Calpain modulators and therapeutic uses thereof
AU2017336523B2 (en)	2016-09-28	2022-07-21	Blade Therapeutics, Inc.	Calpain modulators and therapeutic uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992013549A1 (en) *	1991-02-07	1992-08-20	Research Corporation Technologies, Inc.	Inhibition of cell proliferation by hydrophobic peptides
US5916887A (en) *	1996-09-23	1999-06-29	National Research Council Of Canada	4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
DE19642591A1 (en) *	1996-10-15	1998-04-16	Basf Ag	New piperidine-ketocarboxylic acid derivatives, their production and use
DE19648793A1 (en) *	1996-11-26	1998-05-28	Basf Ag	New benzamides and their application
DE19818614A1 (en) *	1998-04-20	1999-10-21	Basf Ag	New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
CA2328396C (en) *	1998-04-20	2009-02-10	Basf Aktiengesellschaft	New substituted amides, their production and their use
DE19817461A1 (en) *	1998-04-20	1999-10-21	Basf Ag	New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
ES2325140T3 (en) *	1998-04-20	2009-08-26	ABBOTT GMBH & CO. KG	AMIDAS REPLACED WITH HETEROCICLES AS INHIBITORS OF THE CALPAINA.
DE19817459A1 (en) *	1998-04-20	1999-10-21	Basf Ag	New heterocyclic amide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
BR9909819A (en) *	1998-04-20	2000-12-19	Basf Ag	Amide, use of amides, and, pharmaceutical preparation for oral, parenteral or intraperitoneal use
WO1999061423A1 (en) *	1998-05-25	1999-12-02	Basf Aktiengesellschaft	New heterocyclically substituted amides, their production and their use

2001
- 2001-03-26 DE DE10114762A patent/DE10114762A1/en not_active Withdrawn
2002
- 2002-03-26 AU AU2002304785A patent/AU2002304785A1/en not_active Abandoned
- 2002-03-26 WO PCT/EP2002/003399 patent/WO2003080182A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2003080182A1 (en)	2003-10-02
DE10114762A1 (en)	2002-10-02

Similar Documents

Publication	Publication Date	Title
AU2002250331A1 (en)	2002-09-24	7-pyrollyl tetracycline compounds and methods of use thereof
AU2002363236A1 (en)	2003-05-12	Compounds, pharmaceutical compositions and methods of use therefor
AU2002255752A1 (en)	2002-09-24	9-aminoacyl tetracycline compounds and methods of use thereof
AU2002363005A1 (en)	2003-05-06	Derivatives of uk-2a
AU2002324775A1 (en)	2003-03-10	Architecture tool and methods of use
AU2002257936A1 (en)	2002-12-03	Methods of well treatment
AU2002314466A1 (en)	2002-10-15	Withasol and methods of use
AU2002330095A1 (en)	2003-04-07	Flavonoids for treatment of diabetes
AU2002304785A1 (en)	2003-10-08	Use of cysteine protease-inhibitors for treating illnesses
AU2002320525A1 (en)	2003-03-03	Antisense modulation of glioma-associated oncogene-2 expression
AU2002239933A1 (en)	2002-08-12	Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2002338734A1 (en)	2003-07-03	Use of phosphorodiesterase IV inhibitors
AU2002359694A1 (en)	2003-06-30	Compounds and methods
AU2002304626A1 (en)	2003-05-15	Sterilization of surfaces
AU2002303712A1 (en)	2002-11-25	Novel telomerase inhibitors and uses therefor
AU2002367959A1 (en)	2003-12-31	Process for the preparation of oxazolidinones and method of use thereof
EP1578723A3 (en)	2005-10-20	Process for the preparation of oxazolidinones and method of use thereof
AU2002337843A1 (en)	2003-04-22	Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2002350362A1 (en)	2003-07-30	Use of an anti-microtubule agent for the treatment of uveitis
AU2002305868A1 (en)	2002-12-23	Inhibitors of reggamma
AU2002251543A1 (en)	2003-04-17	Novel atisane compound and use thereof
AU2002244086A1 (en)	2002-09-12	Antisense modulation of recql4 expression
AU2002315554A1 (en)	2003-03-03	Antisense modulation of glioma-associated oncogene-3 expression
AU2002257572A1 (en)	2002-09-19	Use of carnitine for increasing testosteron
AU2002311913A1 (en)	2002-12-23	Method of use

Legal Events

Date	Code	Title	Description
2004-02-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase